Rextin-CR Plus Tablet ER
Marketer
Mabril Healthcare Pvt Ltd
Salt Composition
Paroxetine (25mg) + Clonazepam (0.5mg)
Overview Rextin-CR Plus Tablet ER
Deprexin ER is a prescription medication for depression, combining ingredients to elevate mood-regulating brain chemicals and reduce excessive neuronal activity. It can be taken with or without food, ideally at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration precisely, as it carries a risk of dependence. Avoid missed doses; if one is missed, take it immediately. Complete the entire course, even with improvement. Abrupt cessation may cause withdrawal. Common side effects include nausea, vomiting, confusion, memory problems, reduced libido, delayed ejaculation, dizziness, and drowsiness; avoid driving or mentally demanding tasks until the effects are known. Report any unusual mood changes or suicidal thoughts, as these are potential risks. Caution is advised if you have liver disease. Disclose all other medications you're using, as interactions may impact Deprexin ER's efficacy or function. Inform your doctor about pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Rextin-CR Plus Tablet ER
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Rextin-CR Plus Tablet ER
Clinical depression
Major Benefits of Rextin-CR Plus Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rextin-CR Plus Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Rextin-CR Plus Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Confusion
- Memory impairment
- Uncoordinated body movements
- Drowsiness
- Tiredness
- Anorgasmia (decreased orgasm)
- Low sexual desire
- Delayed ejaculation
How to use Rextin-CR Plus Tablet ER:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rextin-CR Plus Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.
How Rextin-CR Plus Tablet ER works:
Extended-release Rextin-CR Plus combines two active pharmaceutical ingredients.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rextin-CR Plus Tablet ER and alcohol is hazardous.
PregnancyUNSAFE
Use of Rextin-CR Plus Extended-Release Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician immediately, as research in both animal and human subjects has revealed substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Rextin-CR Plus tablets are likely unsuitable for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Rextin-CR Plus Extended-Release Tablets.
KidneySAFE IF PRESCRIBED
Extended-release Rextin-CR Plus tablets are likely safe for individuals with kidney disease. Current evidence indicates dose modification may not be necessary, however, a physician's consultation is recommended. Patients with advanced kidney failure may experience increased drowsiness with Rextin-CR Plus.
LiverCAUTION
Patients with hepatic impairment should use Rextin-CR Plus Extended-Release Tablets cautiously. Dosage modification of Rextin-CR Plus Extended-Release Tablets may be necessary; physician consultation is recommended.
What if you forget to take Rextin-CR Plus Tablet ER :
Should you forget a Rextin-CR Plus Tablet ER dose, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Rextin-CR Plus Tablet ER
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |




